{
    "medicine_id": "b21db4b729f63de3de387f089c86fcd0e3dd6b78",
    "platform_id": "DB14048",
    "metadata": {
        "name": "Lokelma 10 g 10g Powder for suspension",
        "composition": "10 g 10g Sodium zirconium cyclosilicate",
        "clinical_particulars": {
            "therapeutic_indications": "Sodium zirconium cyclosilicate is a potassium binder indicated for the treatment of hyperkalemia in adult patients L12822 F130",
            "contraindications": {
                "disease": "Overdose with sodium zirconium cyclosilicate could lead to hypokalemia L12822 F130",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Sodium zirconium cyclosilicate is capable of reducing serum potassium concentrations as quickly as one hour after ingestion and normokalaemia can be achieved typically within 24 to 48 hours L12822 F130 Sodium zirconium cyclosilicate does not affect serum calcium or magnesium concentrations or urinary sodium excretion L12822 F130 A close correlation is observed between starting serum potassium levels and effect size patients with higher starting serum potassium levels have greater reductions in serum potassium L12822 F130 As a consequence of the resultant reduction in serum potassium concentration there is a reduction in urinary potassium excretion as well L12822 F130 In a study of healthy subjects given sodium zirconium cyclosilicate 5 or 10 grams daily for four days a dose dependent reduction in serum potassium concentration and total urinary potassium excretion were accompanied by mean increases in fecal potassium excretion L12822 F130 No statistically significant changes in urinary sodium excretion were observed L12822 F130 Sodium zirconium cyclosilicate has also been observed to bind ammonium in vitro and in vivo thereby removing ammonium and increasing serum bicarbonate levels F130 Patients treated with sodium zirconium cyclosilicate were documented as experiencing an increase of 1 1 mmol L at 5 g once daily 2 3 mmol L at 10 g once daily and 2 6 mmol L at 15 g once daily in bicarbonate compared with a mean increase of 0 6 mmol L for the patients receiving placebo F130 In an environment where other factors affecting renin and aldosterone were not controlled sodium zirconium cyclosilicate demonstrated a dose independent reduction in mean serum aldosterone levels range of 30 to 31 compared with the placebo group 14 F130 No consistent effect on systolic and diastolic blood pressure has yet to be observed F130 Moreover mean reductions in blood urea nitrogen BUN were observed in the 5 g 1 1 mg dL and 10 g 2 0 mg dL three times daily groups compared with small mean increases in the placebo 0 8 mg dL and low dose sodium zirconium cyclosilicate 0 3 mg dL F130",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01072",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The serum concentration of Cefditoren can be decreased when it is combined with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Sodium zirconium cyclosilicate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Sodium zirconium cyclosilicate can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The serum concentration of Cefuroxime can be decreased when it is combined with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Sodium zirconium cyclosilicate may decrease the excretion rate of Memantine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The therapeutic efficacy of Sulpiride can be increased when used in combination with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Mycophenolate mofetil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01344",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB00847",
                        "description": "The bioavailability of Cysteamine can be decreased when combined with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06799",
                        "description": "The therapeutic efficacy of Methenamine can be decreased when used in combination with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB00893",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01592",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09147",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferumoxides resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferric sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11210",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferrous bisglycinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Gleptoferron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferric cation resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14491",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Ritonavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Amprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15623",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of TMC 310911 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "Sodium zirconium cyclosilicate can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The absorption of Palbociclib can be decreased when combined with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "Sodium zirconium cyclosilicate can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}